HC Wainwright increased their FY2024 earnings per share (EPS) estimates for Trevi Therapeutics in a research report issued on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback